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Penetrating aortic ulcer (PAU) of the arch has a focal extent which often represents an adequate anatomic 
target for thoracic endovascular aortic repair (TEVAR). However, the anatomic constraints represented by 
the supra-aortic vessels pose either clinical or technical challenges that increase when the PAU develops 
proximally in the arch. Currently, different types of endografts are commercially available and have been 
used to treat aortic arch lesions. These include branched/fenestrated endografts for a total endovascular 
approach, and standard devices that can be used in combination with open/hybrid surgical operations, with 
the aim to exploit the minimally invasive nature of TEVAR by extending the proximal landing zone when 
necessary. We describe several current techniques adopted in such settings.
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Art of Operative Techniques
Introduction
Penetrating aortic ulcer (PAU) is a focal lesion of the 
arterial intima and media that generally develops due to 
a disruption of an atherosclerotic plaque (1). The natural 
history of PAU is not completely clear, being potentially 
associated with intramural hematoma (IMH) and aortic 
dissection or leading to aortic wall rupture (2). Typically, 
PAUs develop as isolated lesions and are mainly located 
in the descending thoracic aorta (3), with only 7% of 
PAUs in the aortic arch (4). Up to 38% of PAUs have 
abrupt onset with rupture—those presenting with pain 
have been associated with morphologic progression and 
complication (5). For these reasons, the recent European 
Society for Vascular Surgery guidelines on the management 
of thoracic aortic disease recommend the treatment of all 
complicated PAUs (class IIa) (6). For asymptomatic lesions, 
surgical or endovascular repair should be considered in 
the presence of potential predictors such as an ulcer that 
initially measures >20 mm in diameter and >10 mm in 
depth, since these cases were significantly associated with 
disease progression (7). PAUs are typically detected in older 
patients compared to those affected by IMH or dissection. 
For this reason, they present more frequently with co-
morbidities, often making them unfit for open surgical 
repair (8). Open surgery has been associated with high 
morbidity and mortality rates (9–38%) (9). In contrast, 
the solitary nature and focal extent of these lesions makes 
them adequate anatomic targets for thoracic endovascular 
aortic repair (TEVAR). Although several series have 
reported favorable short and mid-term outcomes (3,6-8), 
PAUs developed in the arch are the most challenging to 
treat endovascularly. The anatomic constraints presented 
by the supra-aortic vessels pose either clinical or technical 
challenges that increase with more proximal arch PAU. 
Currently, different types of endografts are commercially 
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available and have been used to treat aortic arch lesions 
(10-12). Aside from the most recent total endovascular 
approach with branched/fenestrated endografts, standard 
devices have been used in combination with open surgical 
maneuvers in the so-called “hybrid” operations, with the 
aim of exploiting the minimally invasive nature of TEVAR 
by extending the proximal landing zone in those cases 
unsuitable for standard endovascular management.
Operative techniques
TEVAR options for treating distal aortic arch PAU 
(landing zone 2)
Hybrid options for left subclavian artery (LSA) and left 
vertebral artery (LVA) revascularization
When a PAU is located in the proximity of the LSA 
origin and requires overstenting for secure sealing at 
the proximal landing zone (“zone 2”) (Figure 1), surgical 
revascularization of the LSA and therefore of the LVA may 
be performed using two different surgical approaches. The 
most frequently used technique is the carotid-subclavian 
bypass with a supra-clavicular surgical access (Figure 2A); this 
type of bypass, generally performed with a prosthetic graft, 
has been increasingly used following the wide adoption 
of “hybrid” operations in the distal aortic arch. Mainly 
indicated for elective cases, it may be performed in a two-
stage fashion when emergency operations require the 
intentional overstenting of the LSA. According to the 
most recent guidelines (6,13), carotid-subclavian bypass 
graft is recommended for LSA revascularization in most 
circumstances: long (>20 cm) descending thoracic aortic 
coverage, especially in the presence of a previous infrarenal 
aortic repair for preventing spinal cord ischemia, left 
coronary artery bypass with the internal mammary artery, 
absent/hypoplastic right vertebral artery, and left upper 
limb vascular access for hemodialysis. LSA coverage without 
revascularization may be performed in emergent settings or 
when the LVA is non-dominant. Other “hybrid” techniques 
for LSA revascularization could be considered during 
TEVAR such as carotid-subclavian transposition or right-to-left 
axillary bypass graft.
Total endovascular options for LSA and LVA 
revascularization
Although different techniques and approaches have been 
adopted for LSA and LVA revascularization, few studies 
report robust data with the use of total endovascular 
solutions. Being predominantly used in urgent settings, the 
parallel graft techniques either in the chimney or periscope 
configuration have gained popularity (Figure 2B). Developed 
as bailout approaches in very demanding circumstances they 
can offer versatility and adaptability using standard off-the-
shelf devices (generally less technically demanding). Major 
concerns are related to the safety of the procedure, with 
a reported stroke rate up to 7.8%, as well as the absence 
of long-term data. Given consequences such as strokes, 
migration, breakage and “gutter-related” endoleaks, which 
are reported in up to 21% of the cases, careful assessment 
is required to determine the safety and durability of the 
aortic arch reconstruction (14). The most elegant and 
anatomical total endovascular approach for a “zone 2” 
lesion is represented by the use of single-arm branched 
endograft. Currently still not on the market, these devices 
produced by Gore (W.L. Gore® and ass.; Flagstaff, AZ, 
USA) and Medtronic® (Medtronic Inc.; Minneapolis, MN, 
USA) are under evaluation in two different trials to assess 
their feasibility and results. A further total endovascular 
solution is represented by the custom-made scallop endograft 
(Terumo Aortic) (Figure 2C), whose main constraint could 
be the variability of subclavian artery anatomy that can limit 
its use in urgent settings since the manufacturer requires 
three weeks’ notice to customize the device (12). A last 
alternative for LSA preservation is represented by the “in 
situ” endovascular fenestration using laser-based catheters. 
Figure 1 Penetrating aortic ulcer (PAU) of the left hemiarch 
which requires proximal TEVAR deployment in Ishimaru zone 2. 
TEVAR, thoracic endovascular aortic repair.
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This procedure is performed through a retrograde upper 
limb arterial access; once the fenestration catheter is 
gently advanced to contact the endograft, a hole in the 
fabric is created, dilated with an angioplasty balloon 
catheter, and lastly, reinforced and stabilized with a stent 
(Figure 2D,E,F).
Sizing and preparation
The patient is placed in the supine position, eventually 
with mild right-side rotation of the left shoulder. Carotid-
subclavian bypass graft is performed under general 
anesthesia, heparinization and neurologic monitoring 
(transcranial-Doppler, EEG). Generally, surgical cutdown 
is performed at the groin to expose the common femoral 
artery since patients with PAUs frequently have severely 
calcified, small diameter iliac and femoral vessels that may 
be prone to complications such as disruption, thrombosis, 
dissection and false aneurysm. Thus, careful evaluation 
of the most appropriate and safest access for endograft 
insertion is mandatory. Occasionally a retroperitoneal 
exposure of iliac arteries to perform an iliac conduit for 
Figure 2 Hybrid and total endovascular techniques for treating PAU which require TEVAR in landing zone 2. (A) Endograft deployment 
in Ishimaru zone 2 with surgical carotid-subclavian bypass graft and retrograde plug embolization of the LSA. A vascular plug is positioned 
proximally to the origin of LVA. (B) LSA preservation using the parallel grafts technique. (C) Scallop device for LSA preservation. TEVAR 
in zone 2 with in situ fenestration for preserving LSA. This technique includes the use of (D) laser catheter for fenestration (E), balloon 
dilatation and (F) stent positioning. PAU, penetrating aortic ulcer; TEVAR, thoracic endovascular aortic repair; LSA, left subclavian artery; 
LVA, left vertebral artery.
A B C
D E F
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endograft delivery is used (Figure 3); in PAU literature, 
this has been required in up to 46% of the cases (6,15). To 
avoid surgical cut-down of the femoral artery in the most 
favorable cases a percutaneous approach can be planned.
A supra-clavicular longitudinal incision is made to 
expose both the LSA and the left common carotid artery. 
Surgical exposure should be preferentially performed 
lateral to the neck in order to identify and preserve the 
brachial plexus and not medially to avoid damage to the 
thoracic duct, which may lead to chylothorax. Sequential 
clamping (subclavian first) is used to perform the bypass 
graft, which should be as short as possible to avoid kinking 
and tunneled under the internal jugular vein. Repair via left 
arm percutaneous access or surgical cut-down is used when 
deploying a scalloped device or parallel graft.
Operation: hybrid procedure for left hemiarch repair
The endograft is introduced and deployed in “zone 2” 
(Ishimaru classification)—between the origin of the left 
common carotid artery and the origin of the LSA. In order 
to avoid a retrograde type 2 endoleak caused by reversal of 
flow in the LVA, the LSA is embolized at its origin with an 
endovascular plug.
Operation: totally endovascular left hemiarch repair
The endograft is introduced with a femoral percutaneous 
or surgical cut-down exposure and access from the left arm 
for a parallel graft to maintain perfusion of LSA. In the 
parallel graft technique, the LSA chimney stent is planned 
to be placed (inside the arch) at least 10 mm proximal to 
the upper fabric edge of the aortic endograft. The two 
devices are ballooned using a “kissing balloon technique” 
as a final procedural step to optimize expansion and mutual 
adaptation. The additional use of rapid ventricular pacing, 
which can be used during the repair of all zones of the 
aortic arch, may play a significant role in reducing endograft 
misplacement as well as the triggering of stent-graft induced 
new intimal damages.
TEVAR options for treating left hemiarch PAU (landing 
zone 1)
Hybrid options for cerebral revascularization
With the widespread use of “hybrid” operations, TEVAR 
has challenged conventional surgery in the transverse aortic 
arch (Figure 4).
Once used only for obstructive disease of the supra-
aortic trunks, right carotid-to-left carotid bypass graft has 
been investigated as a potential alternative to treat patients 
with arch lesions and deemed unfit for conventional repair. 
While results have been promising in some series, experts 
have questioned the feasibility and durability of such types 
Figure 4 Penetrating aortic ulcer (PAU) of the inner curve of 
the aortic arch which requires proximal TEVAR deployment in 
Ishimaru zone 1. TEVAR, thoracic endovascular aortic repair.
Figure 3 Access for endograft delivery: prosthetic conduit using 
the iliac artery as an alternative when percutaneous approach is not 
possible for small and hostile femoral arteries.
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of extra-anatomic reconstruction based on the anatomic 
observation that the distance between the two target 
vessels is generally not enough to guarantee safe sealing. 
Points of concern include: the length of the intervention, 
which includes the carotid-subclavian bypass, the potential 
risk of stroke, and prosthetic graft infection [reported in 
less than 4% of cases (16)]. This type of reconstruction is 
feasible both for elective cases and in an emergency setting, 
when conventional open repair would not be tolerated by 
a fragile patient. Left hemiarch repair using a “hybrid” 
approach with TEVAR has also been described using a 
median sternotomy: in this case, a median mini-sternotomy 
is used to gain access to the origin of the left common 
carotid artery and to the brachiocephalic trunk in the 
chest; at that time, a left common carotid-to-brachiocephalic 
trunk transposition  can be performed. Indeed, this 
approach is more traumatic but guarantees an anatomical 
reconstruction (thus creating a sort of surgical bovine 
trunk) with a longer landing zone (17).
Total endovascular options for cerebral revascularization
As for distal aortic arch lesions, the use of the parallel graft 
technique has been described to maintain antegrade flow 
into the supra-aortic vessels. From a technical perspective, 
even a “triple barrel technique” is feasible and has been 
reported (18-20). This is a viable solution for emergent 
cases or for those patients with “no more room” for a 
conventional repair, either because of clinical or technical 
aspects. Concerns have been raised around the parallel graft 
technique regarding technical difficulty and serious clinical 
consequences (18-20). First, TEVAR with ascending 
chimneys is not recommended with a proximal aortic neck 
diameter up to 42 mm (19). Further, from a technical point 
of view, ideally the radial force exerted from the aortic 
endograft should not compromise the chimney graft, while 
also maintaining an adequate mutual wall apposition. 
Despite the lack of a dedicated mathematical algorithm, 
endograft oversizing is suggested to be up to 30%. In 
addition, the incidence of “gutter-related” type 1a endoleak, 
which ranges from 0% to 44% (18), and the procedure-
related stroke rate is still significant ranging between 4% 
and 7.8% (20).
Single branched endograft
Currently, there are two devices intended for the total 
endovascular treatment of arch pathologies: the Gore® 
TAG® thoracic branched endoprosthesis (W.L. Gore® 
and ass.; Flagstaff, AZ, USA) and the Valiant MonaLSA®, 
(Medtronic® Inc.; Minneapolis, MN, USA). The GORE 
TAG device is built with a pre-cannulated internal 
retrograde branch, which is either 8 mm (for “zone 2” 
lesion) or 12 mm (for “zone 0” lesion) (Figure 5A). The 
Valiant MonaLSA device presents the separate side-branch 
component which is conformed with a proximal flare with 
an intended 1 cm overlap to enhance proximal seal. While 
both the ongoing trials have been designed to evaluate 
device use for LSA preservation, it is expected to use these 
new technologies to treat more proximal sealing zones (21).
Operation: hybrid procedure for arch repair
The patient is positioned in the supine position. This type 
of intervention should always be performed under general 
anesthesia, heparinization and neurologic monitoring 
(transcranial-Doppler, EEG). Surgical access to the 
common carotid artery is performed with a standard 
approach bilaterally at the base of the neck. On the left side, 
an “L-shape” incision is performed to allow easier access 
to the LSA. The prosthetic bypasses are generally tunneled 
anteriorly in the suprajugular fossa but a retropharyngeal 
route has also been described as feasible (16). Prosthetic 
graft bypasses have been described with a variety of 
technical variants, including the use of separated grafts to 
the left common carotid and LSA, or with the use of a pre-
constituted bifurcated graft, or with a direct bypass from 
the right common carotid artery to the LSA and an end-to-
side transposition of the left common carotid artery onto 
the prosthetic graft. To prevent a type 2 endoleak, the LSA 
should be embolized by positioning a vascular plug proximal 
to the origin of the LVA (Figure 5B).
Operation: totally endovascular arch repair
When using parallel or branched grafts, the technical 
aspects are no different from those for LSA preservation 
except that multiple retrograde access from both the 
common carotid arteries should be used for positioning 
and releasing all the covered stents parallel to the aortic 
endograft (Figure 5C). A very important point during 
these maneuvers is the presence of transient, quick carotid 
clamping to prevent distal embolization at the moment 
of the covered stent release. Both the full heparinization 
and the adjunct of a rapid ventricular pacing may limit 
thrombus formation and favor the precise deployment 
of the devices. For the Najuta fenestrated graft, the vital 
maneuver of inserting and advancing the device is achieved 
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by the through-and-through access from the right brachial 
artery. This improves the trackability and pushability of the 
device introduced through the groin.
TEVAR options for arch PAU with landing zone 0
Parallel grafts (using covered stent-graft parallel to 
thoracic endograft)
Similar to “zone 1” cases, the parallel graft technique 
is feasible and a potentially reasonable alternative for 
emergent cases or patients deemed unfit for open repair. 
In case of “zone 0” lesions, it is possible to use: (I) only one 
parallel graft for the brachiocephalic trunk in association 
with a carotid-to-carotid and LSA bypass graft; or (II) 
two parallel grafts for the brachiocephalic trunk and right 
common carotid artery, with/without the LSA bypass graft; 
or finally (III) three parallel grafts to preserve antegrade 
flow to all the supra-aortic vessels. A common finding after 
this type of total endovascular approach is a high incidence 
of “gutter-related” type 1a endoleak that generally has been 
described to increase with the increased number of chimney 
grafts (18-20).
Branched stent graft
Both transverse/proximal aortic arch lesions are the 
ideal target for branched endografts in patients unfit for 
open conventional repair. The current available devices, 
namely the Zenith® arch branched device (Cook Medical; 
Bloomington, IN; USA), Nexus® (Endospan; Herzlia, 
Israel), Inoue® stent-graft (PTMC; Kyoto, Japan), and 
Relay NBS® Plus (Terumo Aortic; Tokyo, Japan) are 
actually devices developed for arch repair using a total 
endovascular approach. Currently they are not available on 
the market because only very few high-volume centers have 
been accredited to use them. As occurred for pure ascending 
TEVAR, arch branched technology is constrained by 
anatomical landmarks, aortic sizing, and curvatures. While 
technical success was in the 84–100% range, mortality rate 
has been reported up to 20% and stroke rate up to 40% 
due to extensive manipulation in severely diseased aortas 
(10,21-23). However, a significant reduction over time 
due to learning curve effects has been reported and the 
incidence of type 1a endoleak has also been reported as less 
than that after total debranching (10,24) (Figure 6A,B).
Fenestrated graft
More recently, custom made endografts have been 
developed for arch disease. The Najuta endograft is a pre-
curved stent with 64 patterns of stent frame and 21 patterns 
of large fenestrations to accommodate the orifices of the 
A B C
Figure 5 Hybrid and total endovascular techniques for treating PAU which require TEVAR in landing zone 1. (A) Single branched 
endograft (Gore® TAG® thoracic branched endoprosthesis from W.L. Gore®. (B) Endograft deployment in landing zone 1 with surgical 
carotid-to-carotid bypass and left carotid-LSA bypass grafts plus plug embolization of the LSA. (C) Double parallel technique using a 
covered stent for the left common carotid artery. The LSA and TEVAR completion is shown. PAU, penetrating aortic ulcer; LSA, left 
subclavian artery; TEVAR, thoracic endovascular aortic repair.
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supra-aortic vessels (Kawasumi Inc.; Tokyo, Japan). The 
delivery system is available with three different degrees 
of pre-curvature to facilitate delivery and positioning. 
The device has been designed to treat mainly saccular 
aneurysm of the distal aortic arch or lesions developing 
from the concavity of the arch curvature by placing its large 
fenestrations across the origins of great vessels with no stent 
reinforcement. Early mortality and stroke rate seem to be 
less than other hybrid or endovascular options, but with a 
higher incidence of type Ia endoleak through fenestrations 
(32.4%) (25) (Figure 6C).
Arch debranching
“Hybrid” aortic arch operations have been classified 
according to the extent of proximal and distal landing 
zones, and the need for circulatory support in the form 
of cardiopulmonary bypass and circulatory arrest. Type 
I debranching defines an operation which is performed 
off-pump with aortic side-biting clamping and bypass 
graft debranching of all supra-aortic vessels (Figure 6D). 
Sometimes this type of procedure could be more easily 
performed on-pump, with circulatory support to better 
manage more challenging cases such as porcelain aorta 
or enlarged (≥40 mm) aorta that could be prone to 
complications such as rupture, bleeding or retrograde 
dissection. In contrast, type II and III “hybrid” aortic arch 
repair require circulatory support and/or circulatory arrest 
with selective antegrade cerebral perfusion to perform 
conventional graft replacement of the ascending aorta and/
or the transverse arch, respectively. This type of intervention 
is optimized by using pre-constituted, multibranched grafts 
with the supra-aortic branches already incorporated in a 
hemodynamically favorable geometry on the main body of 
the prosthesis (17,26,27).
Comments
Open surgical repair is still the gold standard treatment 
for aortic arch diseases, primarily for aneurysms and 
dissections, however new devices and techniques for total/
hybrid endovascular repair are already available to treat 
aortic arch PAUs. These patients are usually older and 
present with severe co-morbidities, making their surgical 
profile high-risk or even prohibitive for open repair when 
compared to those with dissection or aneurysms.
Standardization in such complex cases is difficult; aside 
from the nature of the aortic lesion, the variability of the 
anatomy of the arch and its branches can significantly 
complicate any attempt at using a standardized model. 
Biomedical industries are continually improving the 
technology in their products in attempts to provide 
devices to treat more challenging disease presentations and 
Figure 6 Hybrid and total endovascular techniques for treating PAU which require TEVAR in landing zone 0. (A) Penetrating aortic ulcer 
(PAU) of the inner curve of the aortic arch which requires proximal TEVAR deployment in Ishimaru zone 0. (B) Double branched Relay 
NBS® Plus (Terumo Aortic; Tokyo, Japan). (C) Fenestrated endograft Najuta (Kawasumi Inc.; Tokyo, Japan). (D) Type I “hybrid” aortic 
arch. TEVAR, thoracic endovascular aortic repair.
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anatomy. Current areas of concern include better stent-
graft accommodation and conformability, the correct 
sizing and location of the fenestrations, and the reduction 
of existing mismatch between the soft native aorta and the 
stiffer endografts (23).
In this potentially challenging setting, user experience 
with different devices is crucial in the decision-making 
process, however, the learning curve related to the use of 
new devices should be accounted for, particularly given that 
its effects are usually associated with sub-optimal outcomes. 
Additionally, mid- and long-term results are still lacking for 
all stent-grafts and surgical techniques.
Although these limitations are important, populations 
are aging more world-wide and surgeons will continue 
to face increasingly difficult disease presentations and 
anatomy in coming years. The options for treating them 
with a minimally-invasive approach, even if associated with 
minimally-invasive open techniques such as extra-thoracic 
bypasses, will need to be improved and validated by future 
experience.
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